Market Value4,455,149,000
Total Holdings58
File Date2021-05-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
OYST / Oyster Point Pharma Inc
SENS / Senseonics Holdings, Inc.
SBBP / Strongbridge Biopharma plc
EYRYY / Erytech Pharma
SPT / Sprout Social, Inc.
GLYC / GlycoMimetics, Inc.
MIRM / Mirum Pharmaceuticals, Inc.
MILE / Metromile Inc
OPEN / Opendoor Technologies Inc.
TRIL / Trillium Therapeutics Inc
VTGN / Vistagen Therapeutics, Inc.
IVA / Inventiva S.A. - Depositary Receipt (Common Stock)
BDTX / Black Diamond Therapeutics, Inc.
NET / Cloudflare, Inc.
EAR / Eargo, Inc.
TRVN / Trevena, Inc.
GRTX / Galera Therapeutics, Inc.
XENE / Xenon Pharmaceuticals Inc.
LUMO / Lumos Pharma, Inc.
SVRA / Savara Inc.
AKUS / Akouos Inc
BE / Bloom Energy Corporation
IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF
MEIP / MEI Pharma, Inc.
LQDA / Liquidia Corporation
PANW / Palo Alto Networks, Inc.
STSA / Satsuma Pharmaceuticals Inc
PLTR / Palantir Technologies Inc.
MTCR / Metacrine Inc
ARDX / Ardelyx, Inc.
CSPR / Casper Sleep Inc
PHAS / PhaseBio Pharmaceuticals Inc
DZSI / DZS Inc.
GNCA / Genocea Biosciences Inc
AFMD / Affimed N.V.
CTIC / CTI BioPharma Corp
AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
UPST / Upstart Holdings, Inc.
OBSV / ObsEva SA.
TCON / TRACON Pharmaceuticals, Inc.
VIRX / Viracta Therapeutics, Inc.
ANNX / Annexon, Inc.
GERN / Geron Corporation
MRKR / Marker Therapeutics, Inc.
TPST / Tempest Therapeutics, Inc.
AVEO / AVEO Pharmaceuticals Inc
COUR / Coursera, Inc.
RGLS / Regulus Therapeutics Inc.
ALLK / Allakos Inc.
INZY / Inozyme Pharma, Inc.
DM / Desktop Metal, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
SYBX / Synlogic, Inc.
CSBR / Champions Oncology, Inc.
CRSP / CRISPR Therapeutics AG
TRVI / Trevi Therapeutics, Inc.
AUPH / Aurinia Pharmaceuticals Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
NKTX / Nkarta, Inc.
LXRX / Lexicon Pharmaceuticals, Inc.